中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Chinese Research Group of Gallbladder Cancer

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Shanghai Jiao Tong University School of Medicine
合作者
The First Affiliated Hospital of Anhui Medical University
Anhui Provincial Hospital
First Affiliated Hospital Bengbu Medical College
LanZhou University
Henan Cancer Hospital
The First Affiliated Hospital of Zhengzhou University
The Second Affiliated Hospital of Harbin Medical University
First Affiliated Hospital of Harbin Medical University
Harbin Medical University
First Hospital of Jilin University
Second Hospital of Jilin University
China-Japan Union Hospital, Jilin University
Changshu NO.1 People's Hospital
Changzhou No.2 People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
The First People's Hospital of Taicang
Wuxi Second People's Hospital
Xuzhou Central Hospital
Second Affiliated Hospital of Suzhou University
Nantong University
The First People's Hospital of Nantong
The Affiliated Hospital of Xuzhou Medical University
Second Affiliated Hospital of Nanchang University
The First Affiliated Hospital of Nanchang University
Jiangxi Provincial People's Hopital
Shengjing Hospital
Baotou Central Hospital
Qinghai Provincial People's Hospital
Heping Hospital Affiliated to Changzhi Medical College
First Hospital of Shanxi Medical University
Shanxi Provincial Cancer Hospital
First Affiliated Hospital Xi'an Jiaotong University
Eastern Hepatobiliary Surgery Hospital
Shanghai Fengxian District Central Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Zhongshan Hospital
Shanghai Pudong Hospital
Central Hospital of Minhang District, Shanghai
Putuo District People's Hospital of Shanghai
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Tianjin Medical University Cancer Hospital
First Affiliated Hospital of Xinjiang Medical University
The First Affiliated Hospital of Kunming Medical College
Yinzhou Hospital Affiliated to Medical School of Ningbo University
Shaoxing Second Hospital
Shaoxing People's Hospital
First Affiliated Hospital of Wenzhou Medical University
Sir Run Run Shaw Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Zhejiang Cancer Hospital
Huizhou Municipal Central Hospital
Ningbo No. 1 Hospital
People's Hospital of Hunan Province
Hainan People's Hospital
Taizhou Municipal Hospital
Xinghua City People's Hospital
Tongliao City Hospital
Jiangxi Provincial Cancer Hospital
Shandong Provincial Hospital
Qilu Hospital of Shandong University
The Affiliated Hospital of Qingdao University
Xijing Hospital

关键词

抽象

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

描述

The objectives of the CRGGC are as follows:

1. To study the current diagnosis and treatment of gallbladder cancer in China.

2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.

3. To improve the accurate staging of gallbladder cancer.

4. To standardize the treatment with gallbladder cancer.

日期

最后验证: 09/30/2019
首次提交: 10/23/2019
提交的预估入学人数: 10/23/2019
首次发布: 10/27/2019
上次提交的更新: 10/23/2019
最近更新发布: 10/27/2019
实际学习开始日期: 12/31/2007
预计主要完成日期: 12/30/2020
预计完成日期: 12/30/2025

状况或疾病

Gallbladder Neoplasms

-

资格标准

有资格学习的性别All
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).

- Patients with accessible electronic medical record

Exclusion Criteria:

- Patients with undetermined primary site of cancer.

结果

主要结果指标

1. Overall Survival [5 years]

The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge